Fig. 1.

Mean and changes in mean IOP and number of IOP‐lowering medications from baseline over time in the total effectiveness.^a OAG population with both IOP measurement and number of topical IOP‐lowering medications recorded at baseline (n = 163^b) (A) and patient subgroup with POAG (n = 120) (B). Mean IOP data are shown with standard deviations. p values were based on paired t‐tests evaluating the difference in IOP or number of topical IOP‐lowering medications from baseline to the indicated postoperative visit; p < 0.05 was considered statistically significant. ^aAll effectiveness analyses included one eye per patient; in cases of bilateral implantation, only the first implanted eye was analysed. ^b11 patients were excluded from analysis of the primary outcome measures as they did not have both IOP and IOP‐lowering medication count data at baseline. IOP = intraocular pressure, meds = medications, phaco = phacoemulsification with intraocular lens replacement, OAG = open‐angle glaucoma, POAG = primary open‐angle glaucoma, SD = standard deviation.